Lasantha C Gunasekara

Title: Innovations in Pulmonary Surfactant Treatment by Lasantha C Gunasekara

Introduction

Lasantha C Gunasekara is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of pulmonary medicine through his innovative approaches to treating respiratory conditions. His work focuses on enhancing pulmonary surfactants, which are crucial for proper lung function.

Latest Patents

Lasantha holds a patent for a method of treating pulmonary surfactant dysfunction or respiratory distress syndrome by administering cyclodextrin or a derivative thereof. This invention relates to enhancing surfactants, particularly pulmonary surfactants, and includes methods for producing surfactant enhancement agents. The patent also addresses mitigating oxidative damage to pulmonary surfactants by using cholesterol-sequestrating agents like cyclodextrin. Notably, his research demonstrates that MβCD can restore dysfunctional surfactant removed from the lungs of children with cystic fibrosis and non-CF bronchiolitis to normal function.

Career Highlights

Lasantha is currently associated with Solaero Med Inc., where he continues to develop innovative solutions for respiratory health. His work has the potential to significantly improve treatment outcomes for patients suffering from surfactant dysfunction.

Collaborations

Lasantha collaborates with talented professionals in his field, including Matthias W Amrein and Ryan Pratt. Their combined expertise contributes to advancing research and development in pulmonary treatments.

Conclusion

Lasantha C Gunasekara's innovative work in enhancing pulmonary surfactants represents a significant advancement in respiratory medicine. His contributions have the potential to improve the quality of life for many patients suffering from respiratory distress.